Biologically Responsive Nanosystems Targeting Cardiovascular Diseases Therapy

Author(s): Zhiling Song, Kechen Song, Yi Xiao, Hui Guo, Yizhun Zhu*, Xiaolin Wang*

Journal Name: Current Drug Delivery

Volume 18 , Issue 7 , 2021

Become EABM
Become Reviewer
Call for Editor


Cardiovascular Diseases (CVD) remain the leading cause of mortality and morbidity worldwide. To date, significant progress has been made in developing stimuli-responsive nanosystems that can intrinsically interact with pathological microenvironment to achieve site-specific delivery along with on-demand drug release for precise CVD treatment. Herein, this review summarizes recent advances on smart nanosystems in response to a wide range of biological cues, including pH, enzymes, ROS, shear force, ATP, etc., which can boost drug delivery performance or monitor disease progression in a non-invasive manner. The designs, compositions and main outcomes of the single and multi-responsive nanosystems for drug delivery and/or detection purposes are provided and discussed.

Keywords: Biologically responsive, nanosystems, nanoparticle, drug delivery, stimuli-triggered drug release, cardiovascular diseases.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 26 January, 2021
Page: [880 - 901]
Pages: 22
DOI: 10.2174/1567201818666210127093743
Price: $95

Article Metrics

PDF: 154